The review states that diabetes mellitus typically gives rise to microvascular and macrovascular problems - examples are nephropathy, retinopathy, neuropathy, gastropathy and cardiac myopathy.
A review on comparative study between metformin andhesperidin in the management of diabetic complications
Rohit Chettri, Sairashmi Samanta, Sushil Gurung, Royan Chhettri
- Editor approved · 16 Nov 2026
- September 2024
- DOI 10.56511/jipbs.2024.11302
The question
How do the roles of metformin and hesperidin compare in diabetic complications and the comorbidities that go with them?
- Diabetes mellitus is a very widespread condition with a marked negative effect on global health.
- Flavonoids have drawn much research interest as a way of targeting diabetic complications.
What was done
- A review article that aims to contrast what metformin and hesperidin do, using a systematic approach.
- It covers various diabetic complications and the comorbidities associated with them.
- It also sets out information to justify a study of the two used in combination.
Key findings
It also names an array of comorbidities, for example depression, cognitive decline and Alzheimer’s disease.
Flavonoids have attracted much research as a means of targeting diabetic complications.
Hesperidin, a plant-based flavone glycoside abundant in citrus fruits, has drawn much attention in medical research for its antioxidant, anti-diabetic and hypolipidemic potential.
The review provides information to justify a study of how effective a combined strategy of the two would be against various diabetic complications and in modulating the progression of the disease.
Why it matters
- The review aims to contrast hesperidin and metformin across various diabetic complications and associated comorbidities.
- It offers grounds for a study of whether combining the two is effective against diabetic complications.
How to cite
Rohit Chettri, Sairashmi Samanta, Sushil Gurung, Royan Chhettri. A review on comparative study between metformin andhesperidin in the management of diabetic complications. Journal of Innovations in Pharmaceutical and Biological Sciences. 2024;11(03):08-20. https://doi.org/10.56511/jipbs.2024.11302
- The article at doi.org (the publisher's page and PDF)
- The article on the journal's site
- The journal at the ISSN Portal (ISSN 2349-2759)